<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37570771</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Advances in the Structure of GGGGCC Repeat RNA Sequence and Its Interaction with Small Molecules and Protein Partners.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5801</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules28155801</ELocationID><Abstract><AbstractText>The aberrant expansion of GGGGCC hexanucleotide repeats within the first intron of the <i>C9orf72</i> gene represent the predominant genetic etiology underlying amyotrophic lateral sclerosis (ALS) and frontal temporal dementia (FTD). The transcribed r(GGGGCC)<sub>n</sub> RNA repeats form RNA foci, which recruit RNA binding proteins and impede their normal cellular functions, ultimately resulting in fatal neurodegenerative disorders. Furthermore, the non-canonical translation of the r(GGGGCC)<sub>n</sub> sequence can generate dipeptide repeats, which have been postulated as pathological causes. Comprehensive structural analyses of r(GGGGCC)<sub>n</sub> have unveiled its polymorphic nature, exhibiting the propensity to adopt dimeric, hairpin, or G-quadruplex conformations, all of which possess the capacity to interact with RNA binding proteins. Small molecules capable of binding to r(GGGGCC)<sub>n</sub> have been discovered and proposed as potential lead compounds for the treatment of ALS and FTD. Some of these molecules function in preventing RNA-protein interactions or impeding the phase transition of r(GGGGCC)<sub>n</sub>. In this review, we present a comprehensive summary of the recent advancements in the structural characterization of r(GGGGCC)<sub>n</sub>, its propensity to form RNA foci, and its interactions with small molecules and proteins. Specifically, we emphasize the structural diversity of r(GGGGCC)<sub>n</sub> and its influence on partner binding. Given the crucial role of r(GGGGCC)<sub>n</sub> in the pathogenesis of ALS and FTD, the primary objective of this review is to facilitate the development of therapeutic interventions targeting r(GGGGCC)<sub>n</sub> RNA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaole</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0002-8635-7627</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xinyue</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0001-3231-398X</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jinhan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0008-4434-2658</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Sishi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Xinfei</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0001-8376-2435</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qingfeng</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0009-0000-1405-3849</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shenlin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0153-0578</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing NMR Center, Peking University, Beijing 100087, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22274050</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">G4</Keyword><Keyword MajorTopicYN="N">GGGGCC</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37570771</ArticleId><ArticleId IdType="pmc">PMC10420822</ArticleId><ArticleId IdType="doi">10.3390/molecules28155801</ArticleId><ArticleId IdType="pii">molecules28155801</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ling S.-C., Polymenidou M., Cleveland D.W. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagui C. Structure and Dynamics of DNA and RNA Double Helices Obtained from the GGGGCC and CCCCGG Hexanucleotide Repeats That Are the Hallmark of C9FTD/ALS Diseases. ACS Chem. Neurosci. 2017;8:578&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423440</ArticleId><ArticleId IdType="pubmed">27933757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.-L., DeJesus-Hernandez M., van Blitterswijk M.M., Jansen-West K., Paul J.W., III, Rademakers R., et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Ende E.L., Jackson J.L., White A., Seelaar H., van Blitterswijk M., Van Swieten J.C. Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions. J. Neurol. Neurosurg. Psychiatry. 2021;92:502&#x2013;509. doi: 10.1136/jnnp-2020-325377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325377</ArticleId><ArticleId IdType="pmc">PMC8053328</ArticleId><ArticleId IdType="pubmed">33452054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Chen Z., Yang F., Jiao B., Peng H., Shi Y., Wang Y., Huang F., Wang J., Shen L., et al. Analysis of the GGGGCC Repeat Expansions of the C9orf72 Gene in SCA3/MJD Patients from China. PLoS ONE. 2015;10:e0130336. doi: 10.1371/journal.pone.0130336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0130336</ArticleId><ArticleId IdType="pmc">PMC4470924</ArticleId><ArticleId IdType="pubmed">26083476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-B., Chen H.-J., Peres J.N., Gomez-Deza J., Attig J., &#x160;talekar M., Troakes C., Nishimura A.L., Scotter E.L., Vance C., et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5:1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd K.C., Power R., Ealing J., Hamdalla H. FUS-ALS presenting with myoclonic jerks in a 17-year-old man. Amyotroph. Lateral Scler. Front. Degener. 2019;20:278&#x2013;280. doi: 10.1080/21678421.2019.1582665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1582665</ArticleId><ArticleId IdType="pubmed">30879340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Liu C., Geng Y., Zhu G. Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD. Sci. Rep. 2015;5:16673. doi: 10.1038/srep16673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16673</ArticleId><ArticleId IdType="pmc">PMC4643247</ArticleId><ArticleId IdType="pubmed">26564809</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcoen D., Elias L., Yu X. What does it take to produce a breakthrough drug? Nat. Rev. Drug Discov. 2015;14:161&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">25722234</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamaki Y., Urushitani M. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD. Int. J. Mol. Sci. 2022;23:12508. doi: 10.3390/ijms232012508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232012508</ArticleId><ArticleId IdType="pmc">PMC9604209</ArticleId><ArticleId IdType="pubmed">36293362</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B., Brown R.H., Jr. Silencing strategies for therapy of SOD1-mediated ALS. Neurosci. Lett. 2017;636:32&#x2013;39. doi: 10.1016/j.neulet.2016.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.07.059</ArticleId><ArticleId IdType="pubmed">27507699</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Simon-Sa&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;rourke J.G., Bogdanik L., Muhammad A., Gendron T.F., Kim K.J., Austin A., Cady J., Liu E.Y., Zarrow J., Grant S., et al. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD. Neuron. 2015;88:892&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Zhu Q., Gendron T.F., Saberi S., McAlonis-Downes M., Seelman A., Stauffer J.E., Jafar-Nejad P., Drenner K., Schulte D., et al. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron. 2016;90:535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q., Jiang J., Gendron T.F., McAlonis-Downes M., Jiang L., Taylor A., Garcia S.D., Dastidar S.G., Rodriguez M.J., King P., et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat. Neurosci. 2020;23:615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez C., Todd P. New pathologic mechanisms in nucleotide repeat expansion disorders. Neurobiol. Dis. 2019;130:104515. doi: 10.1016/j.nbd.2019.104515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104515</ArticleId><ArticleId IdType="pmc">PMC6689435</ArticleId><ArticleId IdType="pubmed">31229686</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Daigle J.G., Cunningham K.M., Coyne A.N., Ruan K., Grima J.C., Bowen K.E., Wadhwa H., Yang P., Rigo F., et al. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell. 2018;173:958&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaepfel B.L., Zhang Z., Maulding K., Coyne A.N., Cheng W., Hayes L.R., Lloyd T.E., Sun S., Rothstein J.D. UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction. Cell Rep. 2021;34:108925. doi: 10.1016/j.celrep.2021.108925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108925</ArticleId><ArticleId IdType="pmc">PMC8063722</ArticleId><ArticleId IdType="pubmed">33789100</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Westergard T., Pasinelli P., Trotti D. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene. Neurosci. Lett. 2017;636:16&#x2013;26. doi: 10.1016/j.neulet.2016.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.09.007</ArticleId><ArticleId IdType="pmc">PMC5148671</ArticleId><ArticleId IdType="pubmed">27619540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamiri B., Reddy K., Macgregor R.B., Jr., Pearson C.E. TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins. J. Biol. Chem. 2014;289:4653&#x2013;4659. doi: 10.1074/jbc.C113.502336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C113.502336</ArticleId><ArticleId IdType="pmc">PMC3931028</ArticleId><ArticleId IdType="pubmed">24371143</ArticleId></ArticleIdList></Reference><Reference><Citation>West R.J., Sharpe J.L., Voelzmann A., Munro A.L., Hahn I., Baines R.A., Pickering-Brown S. Co-expression of C9orf72 related dipeptide-repeats over 1000 repeat units reveals age- and combination-specific phenotypic profiles in Drosophila. Acta Neuropathol. Commun. 2020;8:158. doi: 10.1186/s40478-020-01028-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01028-y</ArticleId><ArticleId IdType="pmc">PMC7487709</ArticleId><ArticleId IdType="pubmed">32894207</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin A., Akimoto C., Wuolikainen A., Alstermark H., Jonsson P., Birve A., Marklund S.L., Graffmo K.S., Forsberg K., Br&#xe4;nnstr&#xf6;m T., et al. Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD. Hum. Mol. Genet. 2015;24:3133&#x2013;3142. doi: 10.1093/hmg/ddv064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv064</ArticleId><ArticleId IdType="pubmed">25712133</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman L.D., Bonini N.M. New Roles for Canonical Transcription Factors in Repeat Expansion Diseases. Trends Genet. 2020;36:81&#x2013;92. doi: 10.1016/j.tig.2019.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2019.11.003</ArticleId><ArticleId IdType="pmc">PMC6980727</ArticleId><ArticleId IdType="pubmed">31837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Wang B., Zhou T. The Advance on Frontotemporal Dementia (FTD)&#x2019;s Neuropathology and Molecular Genetics. Mediat. Inflamm. 2022;2022:5003902. doi: 10.1155/2022/5003902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5003902</ArticleId><ArticleId IdType="pmc">PMC9584734</ArticleId><ArticleId IdType="pubmed">36274975</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y.A., Fratta P., Traynor B.J., Chia R. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2020;14:42. doi: 10.3389/fnins.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverria G.V., Cooper T.A. RNA-binding proteins in microsatellite expansion disorders: Mediators of RNA toxicity. Brain Res. 2012;1462:100&#x2013;111. doi: 10.1016/j.brainres.2012.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.030</ArticleId><ArticleId IdType="pmc">PMC3372679</ArticleId><ArticleId IdType="pubmed">22405728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler A.D., Tsuiji H. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS. Brain Res. 2016;1647:19&#x2013;29. doi: 10.1016/j.brainres.2016.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.004</ArticleId><ArticleId IdType="pmc">PMC5003651</ArticleId><ArticleId IdType="pubmed">27059391</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Langenhove T., van der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol. 2012;11:54&#x2013;65. doi: 10.1016/S1474-4422(11)70261-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Fay M.M., Anderson P.J., Ivanov P. ALS/FTD-Associated C9ORF72 Repeat RNA Promotes Phase Transitions In Vitro and in Cells. Cell Rep. 2017;21:3573&#x2013;3584. doi: 10.1016/j.celrep.2017.11.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.11.093</ArticleId><ArticleId IdType="pmc">PMC5741101</ArticleId><ArticleId IdType="pubmed">29262335</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A.R., Selvaraj B.T., Barton S.K., McDade K., Abrahams S., Chandran S., Smith C., Gregory J.M. Improved detection of RNA foci in C9orf72 amyotrophic lateral sclerosis post-mortem tissue using BaseScope&#x2122; shows a lack of association with cognitive dysfunction. Brain Commun. 2020;2:fcaa009. doi: 10.1093/braincomms/fcaa009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa009</ArticleId><ArticleId IdType="pmc">PMC7099934</ArticleId><ArticleId IdType="pubmed">32226938</ArticleId></ArticleIdList></Reference><Reference><Citation>Malnar M., Rogelj B. SFPQ regulates the accumulation of RNA foci and dipeptide repeat proteins from the expanded repeat mutation in C9orf72. J. Cell Sci. 2021;134:jcs256602. doi: 10.1242/jcs.256602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.256602</ArticleId><ArticleId IdType="pmc">PMC7904093</ArticleId><ArticleId IdType="pubmed">33495278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky N.B., Taylor J.P. Bridging biophysics and neurology: Aberrant phase transitions in neurodegenerative disease. Nat. Rev. Neurol. 2019;15:272&#x2013;286. doi: 10.1038/s41582-019-0157-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0157-5</ArticleId><ArticleId IdType="pubmed">30890779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Goodrich K.J., Conlon E.G., Gao J., Erbse A., Manley J.L., Cech T.R. C9orf72 and triplet repeat disorder RNAs: G-quadruplex formation, binding to PRC2 and implications for disease mechanisms. RNA. 2019;25:935&#x2013;947. doi: 10.1261/rna.071191.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.071191.119</ArticleId><ArticleId IdType="pmc">PMC6633194</ArticleId><ArticleId IdType="pubmed">31048495</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Bento-Abreu A., Gendron T.F., Boeynaems S., Bogaert E., Nuyts R., Timmers M., Scheveneels W., Hersmus N., Wang J., et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z., Wang H., Xia Q., Li K., Li K., Jiang X., Xu G., Wang G., Ying Z. Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. Hum. Mol. Genet. 2015;24:2426&#x2013;2441. doi: 10.1093/hmg/ddv005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv005</ArticleId><ArticleId IdType="pubmed">25575510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.-M., Arzberger T., May S., Rentzsch K., Kremmer E., Schmid B., Kretzschmar H.A., Cruts M., Van Broeckhoven C., et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Lu Y.-N., Paul T., Periz G., Banco M.T., Ferr&#xe9;-D&#x2019;amar&#xe9; A.R., Rothstein J.D., Hayes L.R., Myong S., Wang J. A Helicase Unwinds Hexanucleotide Repeat RNA G-Quadruplexes and Facilitates Repeat-Associated Non-AUG Translation. J. Am. Chem. Soc. 2021;143:7368&#x2013;7379. doi: 10.1021/jacs.1c00131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.1c00131</ArticleId><ArticleId IdType="pmc">PMC8610145</ArticleId><ArticleId IdType="pubmed">33855846</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores B.N., Dulchavsky M.E., Krans A., Sawaya M.R., Paulson H.L., Todd P.K., Barmada S.J., Ivanova M.I. Distinct C9orf72-Associated Dipeptide Repeat Structures Correlate with Neuronal Toxicity. PLoS ONE. 2016;11:e0165084. doi: 10.1371/journal.pone.0165084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165084</ArticleId><ArticleId IdType="pmc">PMC5077081</ArticleId><ArticleId IdType="pubmed">27776165</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W., Wang S., Mestre A.A., Fu C., Makarem A., Xian F., Hayes L.R., Lopez-Gonzalez R., Drenner K., Jiang J., et al. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2&#x3b1; phosphorylation. Nat. Commun. 2018;9:51. doi: 10.1038/s41467-017-02495-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02495-z</ArticleId><ArticleId IdType="pmc">PMC5754368</ArticleId><ArticleId IdType="pubmed">29302060</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A., Vale R.D. RNA phase transitions in repeat expansion disorders. Nature. 2017;546:243&#x2013;247. doi: 10.1038/nature22386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22386</ArticleId><ArticleId IdType="pmc">PMC5555642</ArticleId><ArticleId IdType="pubmed">28562589</ArticleId></ArticleIdList></Reference><Reference><Citation>Penumutchu S.R., Chiu L.-Y., Meagher J.L., Hansen A.L., Stuckey J.A., Tolbert B.S. Differential Conformational Dynamics Encoded by the Linker between Quasi RNA Recognition Motifs of Heterogeneous Nuclear Ribonucleoprotein H. J. Am. Chem. Soc. 2018;140:11661&#x2013;11673. doi: 10.1021/jacs.8b05366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.8b05366</ArticleId><ArticleId IdType="pmc">PMC6648666</ArticleId><ArticleId IdType="pubmed">30122033</ArticleId></ArticleIdList></Reference><Reference><Citation>Celona B., Dollen J.V., Vatsavayai S.C., Kashima R., Johnson J.R., Tang A.A., Hata A., Miller B.L., Huang E.J., Krogan N.J., et al. Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. eLife. 2017;6:e19032. doi: 10.7554/eLife.19032.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.19032</ArticleId><ArticleId IdType="pmc">PMC5283830</ArticleId><ArticleId IdType="pubmed">28072389</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.J., Zhang P.W., Pham J.T., Haeusler A.R., Mistry N.A., Vidensky S., Daley E.L., Poth E.M., Hoover B., Fines D.M., et al. RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention. Neuron. 2013;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Poidevin M., Li X., Li Y., Shu L., Nelson D.L., Li H., Hales C.M., Gearing M., Wingo T.S., et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl. Acad. Sci. USA. 2013;110:7778&#x2013;7783. doi: 10.1073/pnas.1219643110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J., Zhang Y., Zhao S., Mao H., Wang Z., Li H., Xu Z. Pur&#x3b1; Repaired Expanded Hexanucleotide GGGGCC Repeat Noncoding RNA-Caused Neuronal Toxicity in Neuro-2a Cells. Neurotox. Res. 2018;33:693&#x2013;701. doi: 10.1007/s12640-017-9803-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-017-9803-0</ArticleId><ArticleId IdType="pubmed">28975482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro A., Lu J., Ozawa D., Nagai Y., Ishihama A. ALS-linked FUS mutations dysregulate G-quadruplex-dependent liquid-liquid phase separation and liquid-to-solid transition. J. Biol. Chem. 2021;297:101284. doi: 10.1016/j.jbc.2021.101284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101284</ArticleId><ArticleId IdType="pmc">PMC8567205</ArticleId><ArticleId IdType="pubmed">34624313</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S.K., Rees E., Miyashita A., Costa A.R., Dodd R.B., Chan F.T.S., Michel C.H., et al. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Walsh M.J., Higginbottom A., Robin Highley J., Dickman M.J., Edbauer D., Ince P.G., Wharton S.B., Wilson S.A., Kirby J., et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Conlon E.G., Manley J.L., Rio D.C. Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains. Genome Res. 2020;30:1705&#x2013;1715. doi: 10.1101/gr.265298.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.265298.120</ArticleId><ArticleId IdType="pmc">PMC7706729</ArticleId><ArticleId IdType="pubmed">33055097</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R., Balendra R., Moens T.G., Preza E., Wilson K.M., Heslegrave A., Woodling N.S., Niccoli T., Gilbert-Jaramillo J., Abdelkarim S., et al. G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. EMBO Mol. Med. 2018;10:22&#x2013;31. doi: 10.15252/emmm.201707850.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201707850</ArticleId><ArticleId IdType="pmc">PMC5760849</ArticleId><ArticleId IdType="pubmed">29113975</ArticleId></ArticleIdList></Reference><Reference><Citation>Millevoi S., Moine H., Vagner S. G-quadruplexes in RNA biology. Wiley Interdiscip. Rev. RNA. 2012;3:495&#x2013;507. doi: 10.1002/wrna.1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1113</ArticleId><ArticleId IdType="pubmed">22488917</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z., Zhang Y., Gendron T.F., Bauer P.O., Chew J., Yang W.-Y., Fostvedt E., Jansen-West K., Belzil V.V., Desaro P., et al. Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. Neuron. 2014;83:1043&#x2013;1050. doi: 10.1016/j.neuron.2014.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.07.041</ArticleId><ArticleId IdType="pmc">PMC4232217</ArticleId><ArticleId IdType="pubmed">25132468</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal M.K. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med. Res. Rev. 2019;39:733&#x2013;748. doi: 10.1002/med.21528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijboom K.E., Abdallah A., Fordham N.P., Nagase H., Rodriguez T., Kraus C., Gendron T.F., Krishnan G., Esanov R., Andrade N.S., et al. CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro. Nat. Commun. 2022;13:6286. doi: 10.1038/s41467-022-33332-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33332-7</ArticleId><ArticleId IdType="pmc">PMC9587249</ArticleId><ArticleId IdType="pubmed">36271076</ArticleId></ArticleIdList></Reference><Reference><Citation>Maity A., Winnerdy F.R., Chen G., Phan A.T. Duplexes Formed by G4C2 Repeats Contain Alternate Slow- and Fast-Flipping G.G Base Pairs. Biochemistry. 2021;60:1097&#x2013;1107. doi: 10.1021/acs.biochem.0c00916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.0c00916</ArticleId><ArticleId IdType="pubmed">33750098</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Periz G., Simko E.A., Shaw P.G., Kim M.-S., Maragakis N.J., Troncoso J.C., Pandey A., Sattler R., et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#x10d;i&#x107; J., Plavec J. G-quadruplex formation of oligonucleotides containing ALS and FTD related GGGGCC repeat. Front. Chem. Sci. Eng. 2016;10:222&#x2013;237. doi: 10.1007/s11705-016-1556-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11705-016-1556-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Mizielinska S., Nicoll A.J., Zloh M., Fisher E.M.C., Parkinson G., Isaacs A.M. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep. 2012;2:srep01016. doi: 10.1038/srep01016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep01016</ArticleId><ArticleId IdType="pmc">PMC3527825</ArticleId><ArticleId IdType="pubmed">23264878</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K., Zamiri B., Stanley S.Y., Macgregor R.B., Pearson C.E. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J. Biol. Chem. 2013;288:9860&#x2013;9866. doi: 10.1074/jbc.C113.452532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C113.452532</ArticleId><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo&#x17e;i&#x10d; T., Zalar M., Rogelj B., Plavec J., &#x160;ket P. Structural Diversity of Sense and Antisense RNA Hexanucleotide Repeats Associated with ALS and FTLD. Molecules. 2020;25:525. doi: 10.3390/molecules25030525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25030525</ArticleId><ArticleId IdType="pmc">PMC7037139</ArticleId><ArticleId IdType="pubmed">31991801</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#x10d;i&#x107; J., Plavec J. ALS and FTD linked GGGGCC-repeat containing DNA oligonucleotide folds into two distinct G-quadruplexes. Biochim. Biophys. Acta (BBA)-Gen. Subj. 2017;1861:1237&#x2013;1245. doi: 10.1016/j.bbagen.2016.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2016.11.018</ArticleId><ArticleId IdType="pubmed">27856299</ArticleId></ArticleIdList></Reference><Reference><Citation>Thys R.G., Wang Y.-H. DNA Replication Dynamics of the GGGGCC Repeat of the C9orf72 Gene. J. Biol. Chem. 2015;290:28953&#x2013;28962. doi: 10.1074/jbc.M115.660324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.660324</ArticleId><ArticleId IdType="pmc">PMC4661408</ArticleId><ArticleId IdType="pubmed">26463209</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#x10d;i&#x107; J., Plavec J. Solution structure of a DNA quadruplex containing ALS and FTD related GGGGCC repeat stabilized by 8-bromodeoxyguanosine substitution. Nucleic Acids Res. 2015;43:8590&#x2013;8600. doi: 10.1093/nar/gkv815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv815</ArticleId><ArticleId IdType="pmc">PMC4787828</ArticleId><ArticleId IdType="pubmed">26253741</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#x10d;i&#x107; J., Plavec J. NMR structure of a G-quadruplex formed by four d(G4C2) repeats: Insights into structural polymorphism. Nucleic Acids Res. 2018;46:11605&#x2013;11617. doi: 10.1093/nar/gky886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky886</ArticleId><ArticleId IdType="pmc">PMC6265483</ArticleId><ArticleId IdType="pubmed">30277522</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Y., Liu C., Cai Q., Luo Z., Miao H., Shi X., Xu N., Fung C.P., Choy T.T., Yan B., et al. Crystal structure of parallel G-quadruplex formed by the two-repeat ALS- and FTD-related GGGGCC sequence. Nucleic Acids Res. 2021;49:5881&#x2013;5890. doi: 10.1093/nar/gkab302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab302</ArticleId><ArticleId IdType="pmc">PMC8191786</ArticleId><ArticleId IdType="pubmed">34048588</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Zhang W., Chang R., Zhang S., Yang G., Zhao G. Liquid-Liquid Phase Separation: Unraveling the Enigma of Biomolecular Condensates in Microbial Cells. Front. Microbiol. 2021;12:751880. doi: 10.3389/fmicb.2021.751880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.751880</ArticleId><ArticleId IdType="pmc">PMC8573418</ArticleId><ArticleId IdType="pubmed">34759902</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Alberti S., Fawzi N.L., Mittag T., Polymenidou M., Rousseau F., Schymkowitz J., Shorter J., Wolozin B., van den Bosch L., et al. Protein Phase Separation: A New Phase in Cell Biology. Trends Cell Biol. 2018;28:420&#x2013;435. doi: 10.1016/j.tcb.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6034118</ArticleId><ArticleId IdType="pubmed">29602697</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand E., Demongin C., Dobra I., Rengifo-Gonzalez J.C., Singatulina A.S., Sukhanova M.V., Lavrik O.I., Pastr&#xe9; D., Hamon L. FUS fibrillation occurs through a nucleation-based process below the critical concentration required for liquid&#x2013;liquid phase separation. Sci. Rep. 2023;13:7772. doi: 10.1038/s41598-023-34558-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-34558-1</ArticleId><ArticleId IdType="pmc">PMC10183042</ArticleId><ArticleId IdType="pubmed">37179431</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Inami H., Oiwa K., Murata Y., Sakai S., Komine O., Sobue A., Iguchi Y., Katsuno M., Yamanaka K. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43. Cell Death Dis. 2020;11:909. doi: 10.1038/s41419-020-03116-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03116-2</ArticleId><ArticleId IdType="pmc">PMC7585435</ArticleId><ArticleId IdType="pubmed">33097688</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J. Phase separation of RNA-binding proteins in physiology and disease: An introduction to the JBC Reviews thematic series. J. Biol. Chem. 2019;294:7113&#x2013;7114. doi: 10.1074/jbc.REV119.007944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.REV119.007944</ArticleId><ArticleId IdType="pmc">PMC6509514</ArticleId><ArticleId IdType="pubmed">30948513</ArticleId></ArticleIdList></Reference><Reference><Citation>Portz B., Lee B.L., Shorter J. FUS and TDP-43 Phases in Health and Disease. Trends Biochem. Sci. 2021;46:550&#x2013;563. doi: 10.1016/j.tibs.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC8195841</ArticleId><ArticleId IdType="pubmed">33446423</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S., Wang J., Papadopoulos D.K., Richter D., Pozniakovsky A., Poser I., Bickle M., Rizk S., Guill&#xe9;n-Boixet J., Franzmann T.M., et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science. 2018;360:918&#x2013;921. doi: 10.1126/science.aar7366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7366</ArticleId><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovtsov V., Nikolic J.M., Goldman J.A., Turck C.W., Chou M.Y., Black D.L. Cooperative Assembly of an hnRNP Complex Induced by a Tissue-Specific Homolog of Polypyrimidine Tract Binding Protein. Mol. Cell. Biol. 2000;20:7463&#x2013;7479. doi: 10.1128/MCB.20.20.7463-7479.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.20.7463-7479.2000</ArticleId><ArticleId IdType="pmc">PMC86300</ArticleId><ArticleId IdType="pubmed">11003644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E., Cambi F. Heterogeneous Nuclear Ribonucleoproteins H and F Regulate the Proteolipid Protein/DM20 Ratio by Recruiting U1 Small Nuclear Ribonucleoprotein through a Complex Array of G Runs. J. Biol. Chem. 2009;284:11194&#x2013;11204. doi: 10.1074/jbc.M809373200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809373200</ArticleId><ArticleId IdType="pmc">PMC2670124</ArticleId><ArticleId IdType="pubmed">19244236</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dusen C.M., Yee L., McNally L.M., McNally M.T. A glycine-rich domain of hnRNP H/F promotes nucleocytoplasmic shuttling and nuclear import through an interaction with transportin 1. Mol. Cell. Biol. 2010;30:2552&#x2013;2562. doi: 10.1128/MCB.00230-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00230-09</ArticleId><ArticleId IdType="pmc">PMC2863714</ArticleId><ArticleId IdType="pubmed">20308327</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Lu L., Sharma A., Yamazaki T., Tang T., Shneider N.A., Manley J.L. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. eLife. 2016;5:e17820. doi: 10.7554/eLife.17820.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y.-Z., Ma J., Dou J.-Z. The Role of TDP-43 in Neurodegenerative Disease. Mol. Neurobiol. 2022;59:4223&#x2013;4241. doi: 10.1007/s12035-022-02847-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02847-x</ArticleId><ArticleId IdType="pubmed">35499795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.B., Lee V.M.-Y., Trojanowski J.Q. Gains or losses: Molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 2011;13:38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A.E., Zerze G.H., Mittal J., Fawzi N.L. ALS Mutations Disrupt Phase Separation Mediated by &#x3b1;-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. Structure. 2016;24:1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Cook C., Gendron T.F., Jansen-West K., del Rosso G., Daughrity L.M., Castanedes-Casey M., Kurti A., Stankowski J.N., Disney M.D., et al. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol. Neurodegener. 2019;14:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon D.A., Stepto A., Au W.H., Adachi Y., Diaper D.C., Hall R., Rekhi A., Boudi A., Tziortzouda P., Lee Y.B., et al. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-&#x3b1; mediates C9orf72-related neurodegeneration. Brain. 2018;141:2908&#x2013;2924. doi: 10.1093/brain/awy241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy241</ArticleId><ArticleId IdType="pmc">PMC6158706</ArticleId><ArticleId IdType="pubmed">30239641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Lammich S., Mackenzie I.R.A., Forn&#xe9; I., Zilow S., Kretzschmar H., Edbauer D., Janssens J., Kleinberger G., Cruts M., et al. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 2013;125:413&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">23381195</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Cabrera G.T., Tran H., Gendron T.F., McKeon J.E., Metterville J., Weiss A., Wightman N., Salameh J., Kim J., et al. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice. Neuron. 2015;88:902&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;R64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai Y., Dohmae N., Hirokawa N. Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule. Neuron. 2004;43:513&#x2013;525. doi: 10.1016/j.neuron.2004.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.07.022</ArticleId><ArticleId IdType="pubmed">15312650</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura A., Fujii R., Watanabe Y., Okabe S., Fukui K., Takumi T. Myosin-Va facilitates the accumulation of mRNA/protein complex in dendritic spines. Curr. Biol. 2006;16:2345&#x2013;2351.</Citation><ArticleIdList><ArticleId IdType="pubmed">17141617</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. Science. 2009;323:1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Niaki A.G., Sarkar J., Cai X., Rhine K., Vidaurre V., Guy B., Hurst M., Lee J.C., Koh H.R., Guo L., et al. Loss of Dynamic RNA Interaction and Aberrant Phase Separation Induced by Two Distinct Types of ALS/FTD-Linked FUS Mutations. Mol. Cell. 2020;77:82&#x2013;94. doi: 10.1016/j.molcel.2019.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.022</ArticleId><ArticleId IdType="pmc">PMC6943187</ArticleId><ArticleId IdType="pubmed">31630970</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasberger H., Bell G.I. Subcellular recruitment by TSG118 and TSPYL implicates a role for zinc finger protein 106 in a novel developmental pathway. Int. J. Biochem. Cell Biol. 2005;37:1421&#x2013;1437. doi: 10.1016/j.biocel.2005.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2005.01.013</ArticleId><ArticleId IdType="pubmed">15833274</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D.M., Cannavino J., Li H., Anderson K.M., Nelson B.R., McAnally J., Bezprozvannaya S., Liu Y., Lin W., Liu N., et al. Severe muscle wasting and denervation in mice lacking the RNA-binding protein ZFP106. Proc. Natl. Acad. Sci. USA. 2016;113:E4494&#x2013;E4503. doi: 10.1073/pnas.1608423113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1608423113</ArticleId><ArticleId IdType="pmc">PMC4978283</ArticleId><ArticleId IdType="pubmed">27418600</ArticleId></ArticleIdList></Reference><Reference><Citation>reibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.-H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hideyama T., Yamashita T., Aizawa H., Tsuji S., Kakita A., Takahashi H., Kwak S. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol. Dis. 2012;45:1121&#x2013;1128. doi: 10.1016/j.nbd.2011.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.033</ArticleId><ArticleId IdType="pubmed">22226999</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.-X., Cho D.-S.C., Wang Q., Lai F., Carter K.C., Nishikura K. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA. 2000;6:755&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369955</ArticleId><ArticleId IdType="pubmed">10836796</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.K., Johnson E.M., Khalili K. Multiple roles for Pur-&#x3b1; in cellular and viral regulation. Cell Cycle. 2009;8:414&#x2013;420. doi: 10.4161/cc.8.3.7585.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.8.3.7585</ArticleId><ArticleId IdType="pmc">PMC2683411</ArticleId><ArticleId IdType="pubmed">19182532</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson E.M., Kinoshita Y., Weinreb D.B., Wortman M.J., Simon R., Khalili K., Winckler B., Gordon J. Role of Pur&#x3b1; in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J. Neurosci. Res. 2006;83:929&#x2013;943. doi: 10.1002/jnr.20806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20806</ArticleId><ArticleId IdType="pubmed">16511857</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel D.C., Wortman M.J., Schiller R.J., Liu H., Gan L., Mellen J.S., Chang C.F., Gallia G.L., Rappaport J., Khalili K., et al. Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Pur&#x3b1; on DNA replication initiated at the JC virus origin. J. Gen. Virol. 2001;82:1543&#x2013;1553. doi: 10.1099/0022-1317-82-7-1543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-82-7-1543</ArticleId><ArticleId IdType="pubmed">11413364</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel D.C., Johnson E.M. PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions. Gene. 2018;643:133&#x2013;143. doi: 10.1016/j.gene.2017.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2017.12.004</ArticleId><ArticleId IdType="pmc">PMC5770235</ArticleId><ArticleId IdType="pubmed">29221753</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili K., Del Valle L., Muralidharan V., Gault W.J., Darbinian N., Otte J., Meier E., Johnson E.M., Daniel D.C., Kinoshita Y., et al. Pur&#x3b1; is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol. Cell. Biol. 2003;23:6857&#x2013;6875. doi: 10.1128/MCB.23.19.6857-6875.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.19.6857-6875.2003</ArticleId><ArticleId IdType="pmc">PMC193944</ArticleId><ArticleId IdType="pubmed">12972605</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbe M.F., Krueger J.J., Loomis R., Otte J., Gordon J. Memory Deficits, Gait Ataxia and Neuronal Loss in the Hippocampus and Cerebellum in Mice That Are Heterozygous for Pur-Alpha. Neuroscience. 2016;337:177&#x2013;190. doi: 10.1016/j.neuroscience.2016.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.09.018</ArticleId><ArticleId IdType="pmc">PMC5458736</ArticleId><ArticleId IdType="pubmed">27651147</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Serrano A., Gerbino V., Giorgi A., Di Francesco L., Nencini M., Bozzo F., Schinin&#xe0; M.E., Bagni C., Cestra G., et al. Nuclear accumulation of mRNAs underlies G4C2 repeat-induced translational repression in a cellular model of C9orf72 ALS. J. Cell Sci. 2015;128:1787&#x2013;1799. doi: 10.1242/jcs.165332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.165332</ArticleId><ArticleId IdType="pubmed">25788698</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle J.G., Krishnamurthy K., Ramesh N., Casci I., Monaghan J., McAvoy K., Godfrey E.W., Daniel D.C., Johnson E.M., Monahan Z., et al. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity. Acta Neuropathol. 2016;131:605&#x2013;620. doi: 10.1007/s00401-015-1530-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1530-0</ArticleId><ArticleId IdType="pmc">PMC4791193</ArticleId><ArticleId IdType="pubmed">26728149</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Salvio M., Piccinni V., Gerbino V., Mantoni F., Camerini S., Lenzi J., Rosa A., Chellini L., Loreni F., Carr&#xec; M.T., et al. Pur-alpha functionally interacts with FUS carrying ALS-associated mutations. Cell Death Dis. 2015;6:e1943. doi: 10.1038/cddis.2015.295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.295</ArticleId><ArticleId IdType="pmc">PMC4632316</ArticleId><ArticleId IdType="pubmed">26492376</ArticleId></ArticleIdList></Reference><Reference><Citation>Muralidharan V., Sweet T., Nadraga Y., Amini S., Khalili K. Regulation of Pur&#x3b1; gene transcription: Evidence for autoregulation of Pur&#x3b1; promoter. J. Cell. Physiol. 2001;186:406&#x2013;413. doi: 10.1002/1097-4652(2000)9999:999&lt;000::AID-JCP1039&gt;3.0.CO;2-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4652(2000)9999:999&lt;000::AID-JCP1039&gt;3.0.CO;2-P</ArticleId><ArticleId IdType="pubmed">11169980</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino L., Pagano B., Fotticchia I., Neidle S., Giancola C. Shedding Light on the Interaction between TMPyP4 and Human Telomeric Quadruplexes. J. Phys. Chem. B. 2009;113:14779&#x2013;14786. doi: 10.1021/jp9066394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp9066394</ArticleId><ArticleId IdType="pubmed">19824637</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris M.J., Wingate K.L., Silwal J., Leeper T.C., Basu S. The porphyrin TmPyP4 unfolds the extremely stable G-quadruplex in MT3-MMP mRNA and alleviates its repressive effect to enhance translation in eukaryotic cells. Nucleic Acids Res. 2012;40:4137&#x2013;4145. doi: 10.1093/nar/gkr1308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1308</ArticleId><ArticleId IdType="pmc">PMC3351169</ArticleId><ArticleId IdType="pubmed">22266651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahler A.M., Williamson J.R., Cech T.R., Prescott D.M. Inhibition of telomerase by G-quartet DNA structures. Nature. 1991;350:718&#x2013;720. doi: 10.1038/350718a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/350718a0</ArticleId><ArticleId IdType="pubmed">2023635</ArticleId></ArticleIdList></Reference><Reference><Citation>Izbicka E., Wheelhouse R., Raymond E., Davidson K.K., Lawrence R.A., Sun D., Windle B.E., Hurley L.H., Von Hoff D.D. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res. 1999;59:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">9973212</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulholland K., Sullivan H.J., Garner J., Cai J., Chen B., Wu C. Three-Dimensional Structure of RNA Monomeric G-Quadruplex Containing ALS and FTD Related G4C2 Repeat and Its Binding with TMPyP4 Probed by Homology Modeling based on Experimental Constraints and Molecular Dynamics Simulations. ACS Chem. Neurosci. 2020;11:57&#x2013;75. doi: 10.1021/acschemneuro.9b00572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.9b00572</ArticleId><ArticleId IdType="pubmed">31800202</ArticleId></ArticleIdList></Reference><Reference><Citation>Disney M.D., Liu B., Yang W.-Y., Sellier C., Tran T., Charlet-Berguerand N., Childs-Disney J.L. A small molecule that targets r(CGG)exp and improves defects in fragile X-associated tremor ataxia syndrome. ACS Chem. Biol. 2012;7:1711&#x2013;1718. doi: 10.1021/cb300135h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb300135h</ArticleId><ArticleId IdType="pmc">PMC3477254</ArticleId><ArticleId IdType="pubmed">22948243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursu A., Wang K.W., Bush J.A., Choudhary S., Chen J.L., Baisden J.T., Zhang Y.J., Gendron T.F., Petrucelli L., Yildirim I., et al. Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD. ACS Chem. Biol. 2020;15:3112&#x2013;3123. doi: 10.1021/acschembio.0c00049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.0c00049</ArticleId><ArticleId IdType="pmc">PMC7788565</ArticleId><ArticleId IdType="pubmed">33196168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursu A., Baisden J.T., Bush J.A., Taghavi A., Choudhary S., Zhang Y.J., Gendron T.F., Petrucelli L., Yildirim I., Disney M.D. A Small Molecule Exploits Hidden Structural Features within the RNA Repeat Expansion That Causes c9ALS/FTD and Rescues Pathological Hallmarks. ACS Chem. Neurosci. 2021;12:4076&#x2013;4089. doi: 10.1021/acschemneuro.1c00470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00470</ArticleId><ArticleId IdType="pmc">PMC9594102</ArticleId><ArticleId IdType="pubmed">34677935</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Lehmer C., Mart&#xed;nez-S&#xe1;nchez A., Rudack T., Beck F., Hartmann H., P&#xe9;rez-Berlanga M., Frottin F., Hipp M.S., Hartl F.U., et al. In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment. Cell. 2018;172:696&#x2013;705. doi: 10.1016/j.cell.2017.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.030</ArticleId><ArticleId IdType="pmc">PMC6035389</ArticleId><ArticleId IdType="pubmed">29398115</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Yang Y., Zhao Y., Li X., Xue Y., Wang S. High-resolution solid-state NMR spectroscopy of hydrated non-crystallized RNA. Chem. Commun. 2019;55:13991&#x2013;13994. doi: 10.1039/C9CC06552K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9CC06552K</ArticleId><ArticleId IdType="pubmed">31687672</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchanka A., Simon B., Althoff-Ospelt G., Carlomagno T. RNA structure determination by solid-state NMR spectroscopy. Nat. Commun. 2015;6:7024. doi: 10.1038/ncomms8024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8024</ArticleId><ArticleId IdType="pmc">PMC4432599</ArticleId><ArticleId IdType="pubmed">25960310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Li X., Wen Z., Zou M., Yu G., Liu X., Mao J., Zhang L., Xue Y., Fu R., et al. Dynamics of base pairs with low stability in RNA by solid-state nuclear magnetic resonance exchange spectroscopy. iScience. 2022;25:105322. doi: 10.1016/j.isci.2022.105322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105322</ArticleId><ArticleId IdType="pmc">PMC9619310</ArticleId><ArticleId IdType="pubmed">36325062</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Wang S. RNA Characterization by Solid-State NMR Spectroscopy. Chemistry. 2018;24:8698&#x2013;8707. doi: 10.1002/chem.201705583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chem.201705583</ArticleId><ArticleId IdType="pubmed">29277936</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Xiang S., Liu X., Pei X., Wu P., Gong Q., Li N., Baldus M., Wang S. Proton-detected solid-state NMR detects the inter-nucleotide correlations and architecture of dimeric RNA in microcrystals. Chem. Commun. 2017;53:12886&#x2013;12889. doi: 10.1039/C7CC07483B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7CC07483B</ArticleId><ArticleId IdType="pubmed">29099144</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>